133 related articles for article (PubMed ID: 2477894)
21. [Percutaneous catheter-embolization in carcinoid liver metastasis].
Jermendy G; Kónya A; Kárpáti P
Orv Hetil; 1985 Jul; 126(30):1851-4. PubMed ID: 4022633
[No Abstract] [Full Text] [Related]
22. Multimodality treatment for gastric carcinoid tumor with liver metastases.
Caplin ME; Hodgson HJ; Dhillon AP; Begent R; Buscombe J; Dick R; Rolles K; Burroughs AK
Am J Gastroenterol; 1998 Oct; 93(10):1945-8. PubMed ID: 9772061
[TBL] [Abstract][Full Text] [Related]
23. Repeated hepatic ischemia in combination with chemotherapy for liver carcinoid metastases.
Van Cutsem E; Penninckx F; Filez L; Kerremans R; Vantrappen G
Acta Gastroenterol Belg; 1993; 56(3-4):292-5. PubMed ID: 8266772
[TBL] [Abstract][Full Text] [Related]
24. Description of patients with midgut carcinoid tumours: clinical database from a Danish centre.
Nykjaer KM; Grønbaek H; Nielsen DT; Christiansen P; Astrup LB
In Vivo; 2007; 21(4):679-84. PubMed ID: 17708366
[TBL] [Abstract][Full Text] [Related]
25. Hepatic artery embolization for treatment of endocrine gastrointestinal tumors with liver metastases.
Stöckmann F; Von Romatowski HJ; Reimold WV; Schuster R; Creutzfeldt W
Z Gastroenterol; 1984 Nov; 22(11):652-60. PubMed ID: 6097061
[TBL] [Abstract][Full Text] [Related]
26. Tolerance to long-term treatment of malignant midgut carcinoid with a highly purified human leukocyte alpha-interferon.
Ahren B; Engman K; Lindblom A
Anticancer Res; 1992; 12(3):881-4. PubMed ID: 1622146
[TBL] [Abstract][Full Text] [Related]
27. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
[TBL] [Abstract][Full Text] [Related]
28. Hepatic dearterialization in the treatment of carcinoid syndrome.
Sjöblom SM; Höckerstedt K; Järvinen H
Acta Chir Scand; 1987 Sep; 153(9):523-9. PubMed ID: 2447716
[TBL] [Abstract][Full Text] [Related]
29. Hepatic artery ligation or embolization and locoregional chemotherapy of liver metastases from colorectal cancer.
Gerard A; Pector JC; Bleiberg H
Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2351-4. PubMed ID: 3137873
[TBL] [Abstract][Full Text] [Related]
30. [Drug embolization in pancreatic carcinoid tumor with metastases to the liver].
Dolgushin BI; Kuchinskiĭ GA; Shatikhin VA; Kalashnikov PA
Sov Med; 1991; (4):90-1. PubMed ID: 1871648
[No Abstract] [Full Text] [Related]
31. [Hepatic chemoembolization for the treatment of carcinoid syndrome].
Kisilevzky N; dos Anjos LC; Carnevale F; de Souza CM; Mott Cde B; Laudana A; Magalhães AC
Rev Hosp Clin Fac Med Sao Paulo; 1995; 50(4):236-9. PubMed ID: 8560156
[TBL] [Abstract][Full Text] [Related]
32. Chemoembolization in the treatment of metastatic ileocolic carcinoid.
Diculescu M; Atanasiu C; Arbănaş T; Croitoru A; Mihalcea A; Becheanu G; Costinean S; Gheorghe L; Capşa R
Rom J Gastroenterol; 2002 Jun; 11(2):141-7. PubMed ID: 12145671
[TBL] [Abstract][Full Text] [Related]
33. [Treatment of metastasized carcinoid tumor of the ileum and cecum with recombinant alpha-2b interferon].
Doberauer C; Niederle N; Kloke O; Kurschel E; Schmidt CG
Onkologie; 1987 Dec; 10(6):340-4. PubMed ID: 2450326
[TBL] [Abstract][Full Text] [Related]
34. [Individual therapeutic procedure in metastatic carcinoid of the small intestine].
Barthel A; Leonhardt U; Stöckmann F; Ramadori G
Leber Magen Darm; 1996 May; 26(3):164, 167-9. PubMed ID: 8709831
[TBL] [Abstract][Full Text] [Related]
35. Embolization of the liver in the management of metastatic carcinoid tumors.
Mårtensson H; Nobin A; Bengmark S; Lunderquist A; Owman T; Sandén G
J Surg Oncol; 1984 Nov; 27(3):152-8. PubMed ID: 6208426
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of temporary liver dearterialization and embolization in patients with metastatic carcinoid tumour.
Nobin A; Månsson B; Lunderquist A
Acta Oncol; 1989; 28(3):419-24. PubMed ID: 2742780
[TBL] [Abstract][Full Text] [Related]
37. Hepatic arterial port systems for treatment of liver metastases: factors affecting patency and adverse events.
Ricke J; Hildebrandt B; Miersch A; Nicolaou A; Warschewske G; Teichgräber U; Lopez Hänninen E; Riess H; Felix R
J Vasc Interv Radiol; 2004 Aug; 15(8):825-33. PubMed ID: 15297586
[TBL] [Abstract][Full Text] [Related]
38. Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumours.
Dominguez S; Denys A; Menu Y; Ruszniewski P
Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S213-5. PubMed ID: 10604133
[TBL] [Abstract][Full Text] [Related]
39. Does radical nephrectomy with immunochemotherapy have any superiority over embolization alone in metastatic renal cell carcinoma? A preliminary report.
Demirci D; Tatlişen A; Ekmekçioğlu O; Ozcan N; Kaya R
Urol Int; 2004; 73(1):54-8. PubMed ID: 15263794
[TBL] [Abstract][Full Text] [Related]
40. Management of hepatic metastasis of gastrointestinal carcinoid tumors.
Landry CS; Scoggins CR; McMasters KM; Martin RC
J Surg Oncol; 2008 Mar; 97(3):253-8. PubMed ID: 18264984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
